We are live on
!
Find out more
CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
-10.13%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$843M
AUM Growth
-$120M
(-12%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-1.43%
Top 10 Holdings %
Top 10 Hldgs %
33.21%
Holding
183
New
3
Increased
20
Reduced
77
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.83M |
| 2 |
Cigna
CI
|
+$3.23M |
| 3 |
GS.PRJ
GOLDMAN SACHS GROUP, INC. 5.50% SER J
GS.PRJ
|
+$639K |
| 4 |
IBM
IBM
|
+$585K |
| 5 |
Valley National Bancorp
VLY
|
+$383K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$6.42M |
| 2 |
AT&T
T
|
+$957K |
| 3 |
Boeing
BA
|
+$945K |
| 4 |
Ford
F
|
+$747K |
| 5 |
Philip Morris
PM
|
+$700K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 21.66% |
| 2 | Financials | 14.07% |
| 3 | Technology | 9.22% |
| 4 | Healthcare | 8.55% |
| 5 | Consumer Staples | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
General Motors
GM
$74.7B
| – | – |
-11,074
| Closed | -$373K |
|
|
K
177
DELISTED
Kellanova
K
| – | – |
-3,089
| Closed | -$203K |
|
178
Opko Health
OPK
$921M
| – | – |
-17,372
| Closed | -$60K |
|
179
Target
TGT
$62.1B
| – | – |
-2,975
| Closed | -$262K |
|
180
Union Pacific
UNP
$183B
| – | – |
-1,300
| Closed | -$212K |
|
|
GNMX
181
DELISTED
Aevi Genomic Medicine Inc
GNMX
| – | – |
-15,143
| Closed | -$19K |
|
|
NCOM
182
DELISTED
National Commerce Corporation
NCOM
| – | – |
-5,720
| Closed | -$236K |
|
|
ESRX
183
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
-67,614
| Closed | -$6.42M |
|
Similar funds
AT
BPCA
HIG
H
LFDLE
PRIG
PO
GC
Charles D. Hyman's Q4 2018 Portfolio in Review
As of Q4 2018, Charles D. Hyman held 183 positions worth $843M, down 12% from $963M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Charles D. Hyman's Q4 2018 filing shows 3 new, 20 increased, 77 reduced and 12 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 15,460 shares worth $3.55M. The largest sale was Express Scripts Holding Company, an estimated $6.42M.
By sector, the portfolio is most concentrated in Industrials at 22% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
- Charles D. Hyman's largest Q4 2018 buy was Vanguard S&P 500 ETF: 15,460 shares worth $3.55M.
- Charles D. Hyman added most to Cigna in Q4 2018, an estimated $3.23M increase.
- Charles D. Hyman's biggest Q4 2018 reduction was AT&T, cutting an estimated $957K.
- Charles D. Hyman fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $6.42M.
- Charles D. Hyman's ten largest holdings make up 33% of its $843M portfolio in Q4 2018.
- Charles D. Hyman opened 3 new positions and closed 12 in Q4 2018.
- Charles D. Hyman's portfolio value fell 12% quarter-over-quarter to $843M.
Based on Charles D. Hyman's 13F filing for Q4 2018, filed 31 Jan 2019.